This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medizinische Hochschule Hannover. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Tim Keys - Innovator in Capsular Polysaccharide Production
Introduction
Tim Keys is a notable inventor based in Uster, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the production of capsular polysaccharides. His innovative work has implications for pharmaceuticals, especially in vaccine development.
Latest Patents
Tim Keys holds a patent titled "Means and methods for producing capsular polysaccharides of low dispersity." This invention relates to in vitro methods for producing capsular polysaccharides with a defined length. The patent also describes compositions that include at least one capsule polymerase, one donor carbohydrate, and one acceptor carbohydrate, with a specific ratio of donor to acceptor carbohydrates ranging from 10:1 to 400:1. Additionally, the invention provides truncated versions of capsule polymerases from serogroups A and X. The applications of this invention extend to pharmaceuticals, particularly vaccines that utilize synthetic capsular polysaccharides of defined lengths.
Career Highlights
Tim Keys is associated with the Medizinische Hochschule Hannover, where he continues to advance his research and innovations. His work has garnered attention for its potential to enhance vaccine efficacy and production methods.
Collaborations
Tim collaborates with notable colleagues, including Angela Romanow and Friedrich Freiberger. Their combined expertise contributes to the advancement of research in the field of biotechnology.
Conclusion
Tim Keys is a pioneering inventor whose work in capsular polysaccharide production is paving the way for advancements in vaccine development. His contributions are vital to the ongoing evolution of pharmaceutical innovations.